• LAST PRICE
    7.74
  • TODAY'S CHANGE (%)
    Trending Up0.55 (7.65%)
  • Bid / Lots
    7.74/ 11
  • Ask / Lots
    7.75/ 10
  • Open / Previous Close
    8.20 / 7.19
  • Day Range
    Low 7.61
    High 8.45
  • 52 Week Range
    Low 3.50
    High 24.90
  • Volume
    18,236,092
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 7.19
TimeVolumeVXRT
09:32 ET13869018.12
09:34 ET6643828.1626
09:36 ET9009738.35
09:38 ET11067798.15
09:39 ET4042828.1
09:41 ET8442287.94
09:43 ET2149847.93
09:45 ET3031327.96
09:48 ET2238987.929
09:50 ET1030547.85
09:52 ET2156767.8944
09:54 ET1340287.93
09:56 ET1999847.8601
09:57 ET1355437.8301
09:59 ET1103897.93
10:01 ET3445978.02
10:03 ET3768798.06
10:06 ET2017508.013
10:08 ET1827397.9699
10:10 ET2153387.8857
10:12 ET2176887.87
10:14 ET1091287.8502
10:15 ET2742707.9
10:17 ET1494747.8299
10:19 ET3167377.785
10:21 ET1412727.79
10:24 ET804577.865
10:26 ET547687.825
10:28 ET1970017.915
10:30 ET2257477.8983
10:32 ET638717.899
10:33 ET653567.82
10:35 ET980917.778
10:37 ET1417477.785
10:39 ET450457.7901
10:42 ET1361607.7698
10:44 ET468637.8119
10:46 ET332017.7899
10:48 ET750127.755
10:50 ET252757.765
10:51 ET2203277.7189
10:53 ET2442967.6982
10:55 ET750187.663
10:57 ET606027.705
11:00 ET578457.71
11:02 ET371007.675
11:04 ET729937.69
11:06 ET711687.6997
11:08 ET358167.675
11:09 ET600147.7099
11:11 ET213287.705
11:13 ET504477.671
11:15 ET606677.645
11:18 ET1159507.6148
11:20 ET1010937.635
11:22 ET1531427.7
11:24 ET816457.71
11:26 ET1210547.6722
11:27 ET338557.67
11:29 ET297167.74
11:31 ET948297.7078
11:33 ET318637.685
11:36 ET332857.695
11:38 ET253247.7125
11:40 ET1029817.7695
11:42 ET1486347.78
11:44 ET391757.79
11:45 ET430977.77
11:47 ET446527.78
11:49 ET172127.76
11:51 ET345897.75
11:54 ET530227.73
11:56 ET386467.72
11:58 ET124377.74
12:00 ET244527.7399
12:02 ET477427.69
12:03 ET400037.74
12:05 ET287227.785
12:07 ET376097.76
12:09 ET1566167.795
12:12 ET287807.795
12:14 ET357157.81
12:16 ET730457.7385
12:18 ET111407.74
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVXRT
Vaxart Inc
879.1M
-16.8x
---
United StatesRAPT
Rapt Therapeutics Inc
878.7M
-13.5x
---
United StatesISEE
Iveric Bio Inc
880.6M
-7.4x
---
United StatesACRS
Aclaris Therapeutics Inc
898.5M
-10.6x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
868.1M
-13.1x
---
United StatesDSGN
Design Therapeutics Inc
861.0M
0.0x
---
As of 2021-08-02

Company Information

Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. It has preclinical RSV non-fusion inhibitor program. It has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.

Contact Information

Headquarters
170 Harbor Way, Suite 300SOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-550-3500
Fax
650-871-8580

Executives

Independent Chairman of the Board
Wouter Latour
President, Chief Executive Officer, Principal Financial Officer, Director
Andrei Floroiu
Senior Vice President, Principal Accounting Officer
Margaret Echerd
Senior Vice President, Chief Scientific Officer
Sean Tucker
Independent Director
Todd Davis

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$879.1M
Revenue (TTM)
$1.7M
Shares Outstanding
122.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.32
EPS
$-0.46
Book Value
$1.12
P/E Ratio
-16.8x
Price/Sales (TTM)
532.8
Price/Cash Flow (TTM)
---
Operating Margin
-2,726.49%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.